{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:04:27Z","timestamp":1769547867009,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.curtheres.2024.100756","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:47:41Z","timestamp":1722354461000},"page":"100756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report"],"prefix":"10.1016","volume":"101","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoMei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LingYa","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2024.100756_bib0001","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2020-322339","article-title":"First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial","volume":"71","author":"Jongsma","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.curtheres.2024.100756_bib0002","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.cgh.2023.03.001","article-title":"Upadacitinib is effective and safe in both ulcerative colitis and Crohn's disease: prospective real-world experience","volume":"21","author":"Friedberg","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2024.100756_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.07.002","article-title":"ATM in DNA repair in cancer","volume":"203","author":"Jin","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2024.100756_bib0004","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024853118","article-title":"Telomere dysfunction instigates inflammation in inflammatory bowel disease","volume":"118","author":"Chakravarti","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.curtheres.2024.100756_bib0005","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.3390\/ijms222413390","article-title":"JAK inhibition prevents DNA damage and apoptosis in testicular ischemia-reperfusion injury via modulation of the ATM\/ATR\/Chk pathway","volume":"22","author":"Khashab","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.curtheres.2024.100756_bib0006","first-page":"e28981","article-title":"Glucocorticoids-induced neuropsychiatric disorders in patients with inflammatory bowel disease: a systematic review","volume":"14","author":"Ali","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.curtheres.2024.100756_bib0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40272-023-00590-x","article-title":"The future of advanced therapies for pediatric Crohn's disease","volume":"25","author":"Gallagher","year":"2023","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.curtheres.2024.100756_bib0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MPG.0000000000000589","article-title":"Adalimumab therapy in children with Crohn disease previously treated with infliximab","volume":"60","author":"Cozijnsen","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.curtheres.2024.100756_bib0009","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/bjc.2015.229","article-title":"Gene therapy with SOCS1 for gastric cancer induces G2\/M arrest and has an antitumour effect on peritoneal carcinomatosis","volume":"113","author":"Natatsuka","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.curtheres.2024.100756_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41419-018-0812-6","article-title":"CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.curtheres.2024.100756_bib0011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2024.100756_bib0012","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.curtheres.2024.100756_bib0013","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamadermatol.2023.0391","article-title":"Efficacy and safety of upadacitinib treatment in adolescents with moderate-to-severe atopic dermatitis","volume":"159","author":"Paller","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.curtheres.2024.100756_bib0014","first-page":"izad300","article-title":"Single-center experience with upadacitinib for adolescents with refractory inflammatory bowel disease","author":"Spencer","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.curtheres.2024.100756_bib0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/ibd\/izad048","article-title":"Rapid clinical remission with upadacitinib in a pediatric patient with refractory Crohn's disease","volume":"29","author":"Collen","year":"2023","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:08:51Z","timestamp":1734167331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":15,"alternative-id":["S0011393X24000262"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100756","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100756"}}